Shigella hijacks the glomulin–cIAPs–inflammasome axis to promote inflammation
- 30 November 2017
- journal article
- research article
- Published by Springer Nature in EMBO Reports
- Vol. 19 (1) , 89-101
Abstract
Shigella deploys a unique mechanism to manipulate macrophage pyroptosis by delivering the IpaH7.8 E3 ubiquitin ligase via its type III secretion system. IpaH7.8 ubiquitinates glomulin (GLMN) and elicits its degradation, thereby inducing inflammasome activation and pyroptotic cell death of macrophages. Here, we show that GLMN specifically binds cellular inhibitor of apoptosis proteins 1 and 2 (cIAP1 and cIAP2), members of the inhibitor of apoptosis (IAP) family of RING‐E3 ligases, which results in reduced E3 ligase activity, and consequently inflammasome‐mediated death of macrophages. Importantly, reducing the levels of GLMN in macrophages via IpaH7.8, or siRNA‐mediated knockdown, enhances inflammasome activation in response to infection by Shigella, Salmonella, or Pseudomonas, stimulation with NLRP3 inflammasome activators (including SiO2, alum, or MSU), or stimulation of the AIM2 inflammasome by poly dA:dT. GLMN binds specifically to the RING domain of both cIAPs, which inhibits their self‐ubiquitination activity. These findings suggest that GLMN is a negative regulator of cIAP‐mediated inflammasome activation, and highlight a unique Shigella stratagem to kill macrophages, promoting severe inflammation. Synopsis Inflammasomes induce caspase‐1 activation, cytokine production and macrophage pyroptosis upon bacterial infection. GLMN, an inhibitor of RING‐type E3 ligases, targeted by the Shigella effector IpaH7.8, negatively regulates inflammasomes by interfering with cIAP E3 ligase activities. cIAP1 and cIAP2 E3 ligases, but not XIAP, promote NLR inflammasome activation. Glomulin (GLMN) interacts with cIAP1 and cIAP2 to inhibit self‐ubiquitination of both cIAPs. Shigella IpaH7.8 ubiquitinates GLMN, promoting its degradation and inflammasome activation. A serine residue in the cIAP RING domain is critical for GLMN interaction, and inflammasome activation.Keywords
Funding Information
- a Grant‐in‐Aid for Specially Promoted Research (23000012)
- a Grant‐in‐Aid for Scientific Research (16K08772)
- a Grant‐in‐Aid for Young Scientists (19790315)
- the Research Grant of Takeda Science Foundation
- Kato Memorial Bioscience Foundation
- University of Tokyo
- Astellas Foundation for Research on Metabolic Disorders
- the Uehara Memorial Foundation Research Fellowship
- the JSPS Excellent Young Researchers Overseas Visit Program (21・10053)
- The Japan Initiative for Global Research Network on Infectious Diseases
- Grants from the Yakult Central Institute
This publication has 41 references indexed in Scilit:
- Activation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumoniaJournal of Clinical Investigation, 2013
- Deubiquitinases Regulate the Activity of Caspase-1 and Interleukin-1β Secretion via Assembly of the InflammasomeJournal of Biological Chemistry, 2013
- Modulation of immune signalling by inhibitors of apoptosisTrends in Immunology, 2012
- Structure of a Glomulin-RBX1-CUL1 Complex: Inhibition of a RING E3 Ligase through Masking of Its E2-Binding SurfaceMolecular Cell, 2012
- The Glomuvenous Malformation Protein Glomulin Binds Rbx1 and Regulates Cullin RING Ligase-Mediated Turnover of Fbw7Molecular Cell, 2012
- Sensing and reacting to microbes through the inflammasomesNature Immunology, 2012
- Shigella deploy multiple countermeasures against host innate immune responsesCurrent Opinion in Microbiology, 2011
- Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasomeProceedings of the National Academy of Sciences, 2010
- cIAP Proteins: Keystones in NOD Receptor Signal TransductionImmunity, 2009
- Mutations in a Novel Factor, Glomulin, Are Responsible for Glomuvenous Malformations (“Glomangiomas”)The American Journal of Human Genetics, 2002